Gastrointestinal Tumors
Pipeline Programs↗
Active Trials↗
Companies Involved↗
Gastrointestinal Tumors is an early-stage landscape with 0 programs across 6 companies. The most active players are Sichuan Baili Pharmaceutical Co., Ltd., Pfizer, Shanghai Juncell Therapeutics.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Sichuan Baili Pharmaceutical Co., Ltd.
0 programs
Pfizer
0 programs
Shanghai Juncell Therapeutics
0 programs
Taiho Oncology, Inc.
0 programs
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
0 programs
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
0 programs
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
26
clinical trials
Clinical Trials
Trial Activity
26 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)